NCT05118178View on ClinicalTrials.gov

Atherosclerosis in Chemotherapy-related Cardiotoxicity

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

September 15, 2024

Study Completion Date

March 15, 2025

Conditions
CardiotoxicityAtherosclerosis
Interventions
DIAGNOSTIC_TEST

echocardiography, computed tomography

echocardiography - including GLS and MWI computed tomography - with calcium score index

Trial Locations (1)

Unknown

National Institute of Oncology, Warsaw

All Listed Sponsors
collaborator

Polish Cardiac Society

OTHER

collaborator

Servier

INDUSTRY

lead

Maria Sklodowska-Curie National Research Institute of Oncology

OTHER

NCT05118178 - Atherosclerosis in Chemotherapy-related Cardiotoxicity | Biotech Hunter | Biotech Hunter